- Home
- ARMP vs ATNI Comparison
ARMP vs ATNI Comparison
Compare ARMP & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | ATNI |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 392.6M |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ARMP | ATNI |
|---|---|---|
| Price | $9.69 | $26.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 43.0K | ★ 81.9K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | ★ 4.49% |
| EPS Growth | ★ 53.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $729,075,000.00 |
| Revenue This Year | N/A | $3.60 |
| Revenue Next Year | N/A | $1.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.90 | $13.76 |
| 52 Week High | $13.75 | $30.45 |
Technical Indicators
Market Signals| Indicator | ARMP | ATNI |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 50.65 |
| Support Level | $5.14 | $21.15 |
| Resistance Level | $12.23 | $26.80 |
| Average True Range (ATR) | 1.09 | 1.48 |
| MACD | -0.24 | -0.46 |
| Stochastic Oscillator | 2.16 | 42.21 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.